Article Text
Abstract
Over 800 000 people in the UK are demented. Alzheimer's disease, dementia with Lewy bodies, vascular dementia and frontotemporal lobar degeneration account for the majority. Although detailed clinical assessment forms the basis of evaluating a patient with cognitive impairment, structural and functional imaging techniques are increasingly being used. Neuroimaging can identify changes to supplement the clinical diagnosis and help to distinguish dementia subtypes. This may be important for treatment, prognosis and care planning. Furthermore, early changes on structural and functional imaging may have a role in preclinical detection, perhaps allowing people to start any treatments early. In this review, we explain the tools available to the neuroradiologist and examine the implications of imaging findings in assessing patients with cognitive impairment or dementia.
- Alzheimer-S Disease
- Dementia
- Vascular Dementia
- Lewy Body
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Biomarkers in dementia: clinical utility and new directions
- Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias
- An algorithmic approach to structural imaging in dementia
- Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer’s disease
- Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia
- Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia
- Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer’s disease
- Alzheimer's disease: mimics and chameleons
- Using visual rating to diagnose dementia: a critical evaluation of MRI atrophy scales
- Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review